Literature DB >> 22271514

STAT3 interacts directly with Hsp90.

Earl Prinsloo1, Adam H Kramer, Adrienne L Edkins, Gregory L Blatch.   

Abstract

Heat shock protein 90 (Hsp90) functionally modulates signal transduction. The signal transducer and activator of transcription 3 (STAT3) mediates interleukin-6 family cytokine signaling. Aberrant activation and mutation of STAT3 is associated with oncogenesis and immune disorders, respectively. Hsp90 and STAT3 have previously been shown to colocalize and coimmunoprecipitate in common complexes. Surface plasmon resonance spectroscopy revealed a direct, high affinity specific interaction between recombinant Hsp90β and STAT3β in the presence and absence of adenosine triphosphate (ATP) in molar excess. Furthermore, comparative analysis using a phosphomimetic mutation at tyrosine 705 showed that the direct interaction appeared to favor neither unactivated nor activated STAT3. Destabilizing mutation of STAT3 at arginine residues 414/417 to alanine in the DNA-binding domain, previously shown to disrupt nuclear translocation in vivo, reduced interaction with a STAT3 DNA binding site oligonucleotide and Hsp90β in vitro, indicating that STAT3 requires a functional DNA-binding domain for full direct interaction with Hsp90. Site-directed mutagenesis of a mammalian STAT3-EGFP-N1 fusion construct at RR414/417 and subsequent transfection into human MCF7 epithelial breast cancer cells showed no impaired nuclear translocation when observed by confocal laser scanning microscopy. However, costaining for Hsp90α/β isoforms and colocalization analysis revealed a defined decrease in pixel-on-pixel colocalization compared with the wild-type confirming the requirement of the DNA-binding domain for high-affinity interaction.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271514     DOI: 10.1002/iub.607

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  13 in total

1.  HSP110 promotes colorectal cancer growth through STAT3 activation.

Authors:  K Berthenet; A'dem Bokhari; A Lagrange; G Marcion; C Boudesco; S Causse; A De Thonel; M Svrcek; A R Goloudina; S Dumont; A Hammann; D S Biard; O N Demidov; R Seigneuric; A Duval; A Collura; G Jego; C Garrido
Journal:  Oncogene       Date:  2016-11-07       Impact factor: 9.867

2.  Myocyte-Derived Hsp90 Modulates Collagen Upregulation via Biphasic Activation of STAT-3 in Fibroblasts during Cardiac Hypertrophy.

Authors:  Ritwik Datta; Trisha Bansal; Santanu Rana; Kaberi Datta; Ratul Datta Chaudhuri; Mamta Chawla-Sarkar; Sagartirtha Sarkar
Journal:  Mol Cell Biol       Date:  2017-03-01       Impact factor: 4.272

Review 3.  Contribution of chaperones to STAT pathway signaling.

Authors:  Claire E Bocchini; Moses M Kasembeli; Soung-Hun Roh; David J Tweardy
Journal:  JAKSTAT       Date:  2014-10-30

Review 4.  STAT3 inhibitors: finding a home in lymphoma and leukemia.

Authors:  Javier Munoz; Navjot Dhillon; Filip Janku; Stephanie S Watowich; David S Hong
Journal:  Oncologist       Date:  2014-04-04

Review 5.  Ubiquitin-mediated regulation of JAK-STAT signaling in embryonic stem cells.

Authors:  Shigetsugu Hatakeyama
Journal:  JAKSTAT       Date:  2012-07-01

Review 6.  Targeting Hsp90 in urothelial carcinoma.

Authors:  Mahmoud Chehab; Tiffany Caza; Kamil Skotnicki; Steve Landas; Gennady Bratslavsky; Mehdi Mollapour; Dimitra Bourboulia
Journal:  Oncotarget       Date:  2015-04-20

7.  Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia.

Authors:  Sandip N Chakraborty; Xiaohong Leng; Bastianella Perazzona; Xiaoping Sun; Yu-Hsi Lin; Ralph B Arlinghaus
Journal:  Genes Cancer       Date:  2016-05

8.  Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.

Authors:  Roberto Gomez-Casal; Michael W Epperly; Hong Wang; David A Proia; Joel S Greenberger; Vera Levina
Journal:  Oncotarget       Date:  2015-12-29

9.  Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia.

Authors:  Timothy L Chen; Nikhil Gupta; Amy Lehman; Amy S Ruppert; Lianbo Yu; Christopher C Oakes; Rainer Claus; Christoph Plass; Kami J Maddocks; Leslie Andritsos; Jeffery A Jones; David M Lucas; Amy J Johnson; John C Byrd; Erin Hertlein
Journal:  Oncotarget       Date:  2016-05-10

10.  The Malarial Exported PFA0660w Is an Hsp40 Co-Chaperone of PfHsp70-x.

Authors:  Michael O Daniyan; Aileen Boshoff; Earl Prinsloo; Eva-Rachele Pesce; Gregory L Blatch
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.